Docetaxel Hydroxy-tert-butyl-carbamate
|
|
Docetaxel Hydroxy-tert-butyl-carbamate Eigenschaften
- Schmelzpunkt:
- 165-168°C
- Siedepunkt:
- 932.9±65.0 °C(Predicted)
- Dichte
- 1.41±0.1 g/cm3(Predicted)
- storage temp.
- -20°C Freezer
- L?slichkeit
- Chloroform (Slightly, Heated), Ethyl Acetate (Slightly), Methanol (Slightly)
- Aggregatzustand
- Solid
- pka
- 10.86±0.46(Predicted)
- Farbe
- White to Off-White
Sicherheit
Docetaxel Hydroxy-tert-butyl-carbamate Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White SolidVerwenden
A metabolite of Docetaxel, an antineoplastic. An antimitotic agent that promotes the assembly of microtublules and inhibits their depolymerization to free tubulinDocetaxel Hydroxy-tert-butyl-carbamate Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Docetaxel Hydroxy-tert-butyl-carbamate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 20)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
China National Standard Pharmaceutical Corporation Limited | +8615391658522 |
overseasales@yongstandards.com | China | 11922 | 58 |
J & K SCIENTIFIC LTD. | 010-82848833 400-666-7788 |
jkinfo@jkchemical.com | China | 94657 | 76 |
Chemsky(shanghai)International Co.,Ltd. | 021-50135380 |
shchemsky@sina.com | China | 32321 | 50 |
Shenzhen Pharma Technology Co., Ltd. | 0755-86648230 |
pharma08@sina.com | China | 166 | 58 |
Shenzhen Polymeri Biochemical Technology Co., Ltd. | +86-400-002-6226 +86-13028896684; |
sales@rrkchem.com | China | 57423 | 58 |
Hubei Xinyang Medical Technology Co., Ltd | 15347293736 15347293736 |
2853117764@qq.com | China | 8871 | 58 |
Energy Chemical | 021-58432009 400-005-6266 |
marketing1@energy-chemical.com | China | 44807 | 58 |
QUALITY CONTROL SOLUTIONS LTD. | 0755-66853366; 13670046396 |
ORDERS@QCSRM.COM | China | 24342 | 58 |
Shenzhen Roark Pharma-Tec Co., Ltd. | 13128912434 |
2880126944@qq.com | China | 2577 | 58 |
LGC Science (Shanghai) Ltd. | 17717235263 |
cindy.yang@lgcgroup.com | China | 17730 | 58 |
154044-57-2()Verwandte Suche:
- Docetaxel Metabolite 2, Hydroxy Taxotere, RPR 104952
- Benzenepropanoic acid, α-hydroxy-β-[[(2-hydroxy-1,1-dimethylethoxy)carbonyl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl est...
- Docetaxel Impurity 63
- Benzenepropanoic acid, α-hydroxy-β-[[(2-hydroxy-1,1-dimethylethoxy)carbonyl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
- RPR 104952/Docetaxel Hydroxy-tert-butyl-carbamate
- 154044-57-2
- C43H53NO15
- Inhibitors
- Intermediates & Fine Chemicals
- Metabolites & Impurities
- Pharmaceuticals
- All Inhibitors